Inogen Inc (INGN)
7.13
+0.11
(+1.57%)
USD |
NASDAQ |
May 03, 16:00
7.13
0.00 (0.00%)
After-Hours: 16:00
Inogen Cash from Operations (Quarterly): -3.148M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -3.148M |
September 30, 2023 | 2.185M |
June 30, 2023 | 4.03M |
March 31, 2023 | -6.301M |
December 31, 2022 | -15.48M |
September 30, 2022 | -9.483M |
June 30, 2022 | 5.531M |
March 31, 2022 | -18.10M |
December 31, 2021 | 6.498M |
September 30, 2021 | -2.994M |
June 30, 2021 | 17.27M |
March 31, 2021 | 2.86M |
December 31, 2020 | 16.20M |
September 30, 2020 | 6.745M |
June 30, 2020 | 13.53M |
March 31, 2020 | 0.54M |
December 31, 2019 | 9.389M |
September 30, 2019 | 14.60M |
June 30, 2019 | 18.43M |
March 31, 2019 | -1.824M |
December 31, 2018 | 12.34M |
September 30, 2018 | 14.38M |
Date | Value |
---|---|
June 30, 2018 | 21.02M |
March 31, 2018 | 12.24M |
December 31, 2017 | 13.01M |
September 30, 2017 | 17.38M |
June 30, 2017 | 16.90M |
March 31, 2017 | 13.21M |
December 31, 2016 | 5.182M |
September 30, 2016 | 9.055M |
June 30, 2016 | 12.02M |
March 31, 2016 | 4.777M |
December 31, 2015 | 12.56M |
September 30, 2015 | 11.85M |
June 30, 2015 | 7.69M |
March 31, 2015 | 6.061M |
December 31, 2014 | 4.329M |
September 30, 2014 | 3.208M |
June 30, 2014 | 9.49M |
March 31, 2014 | -1.33M |
December 31, 2013 | 1.989M |
September 30, 2013 | 4.601M |
June 30, 2013 | 4.184M |
March 31, 2013 | 2.693M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-18.10M
Minimum
Mar 2022
18.43M
Maximum
Jun 2019
3.279M
Average
4.03M
Median
Jun 2023
Cash from Operations (Quarterly) Benchmarks
Oragenics Inc | -1.102M |
Palatin Technologies Inc | -10.48M |
Oramed Pharmaceuticals Inc | -1.418M |
vTv Therapeutics Inc | -2.914M |
G1 Therapeutics Inc | -12.79M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 4.128M |
Cash from Financing (Quarterly) | -0.014M |
Free Cash Flow | -30.24M |
Free Cash Flow Per Share (Quarterly) | -0.4053 |
Free Cash Flow to Equity (Quarterly) | -9.45M |
Free Cash Flow to Firm (Quarterly) | -9.45M |
Free Cash Flow Yield | -18.30% |